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Contrast Ultrasound for the Assessment of
Peripheral Arterial Disease Severity
Jonathan R. Lindner, MD, FACC,* Lisa Womack, MS,† Eugene J. Barrett, MD, PHD,‡
Judy Weltman, MS,† Wendy Price, RN,† Nancy L. Harthun, MD,§
Sanjiv Kaul, MD, FACC,* James T. Patrie, MS†
Portland, Oregon; and Charlottesville, Virginia
O B J E C T I V E S We hypothesized that stress-rest perfusion imaging of skeletal muscle in the lower
extremity with contrast-enhanced ultrasound (CEU) could evaluate the severity of peripheral arterial
disease (PAD).
B A C KG ROUND Perfusion imaging may provide valuable quantitative information on PAD,
particularly in patients with diabetes in whom microvascular functional abnormalities are common.
METHOD S Study subjects included 26 control subjects and 39 patients with symptomatic PAD, 19
of whom had type 2 diabetes mellitus. A modiﬁed treadmill exercise test was performed to determine
exercise time to development of claudication. Multilevel pulse-volume recordings and ankle-brachial
index (ABI) at rest and post-exercise ABI were measured in both extremities. Microvascular blood ﬂow
in the gastrocnemius and soleus muscles was measured at rest and after 2 min of calibrated
plantar-ﬂexion exercise.
R E S U L T S During exercise, claudication did not occur in normal subjects and occurred earlier in PAD
patients with diabetes than without (median time 1.2 min [95% conﬁdence interval (CI) 0.6 to 2.5] vs. 3.0
min [95% CI 2.1 to 6.0], p  0.01). Compared to control subjects, patients with PAD had lower skeletal
muscle blood ﬂow during plantar-ﬂexion exercise and lower ﬂow reserve on CEU. After adjusting for
diabetes, the only diagnostic tests that predicted severity of disease by claudication threshold were CEU
exercise blood ﬂow and ﬂow reserve (odds ratios 0.67 [95% CI 0.51 to 0.88; p  0.003] and 0.64 [95%
CI 0.46 to 0.89, p  0.008], respectively). A quasi-likelihood information analysis incorporating all
non-invasive diagnostic tests indicated that the best models for predicting severity of disease were the
combination of diabetes and either exercise blood ﬂow or ﬂow-reserve on CEU.
CONC L U S I O N S Perfusion imaging of limb skeletal during exercise and measurement of absolute
ﬂow reserve can provide valuable information on the severity PAD. This strategy may be useful for
evaluating the total impact of disease in patients with complex disease or those with coexisting
functional abnormalities of ﬂow regulation. (J Am Coll Cardiol Img 2008;1:343–50) © 2008 by the
American College of Cardiology Foundation
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344any noninvasive ethods commonly
used for diagnosing peripheral arterial
disease (PAD) rely on the detection
of pressure gradients, such as the
nkle-brachial index (ABI) and Doppler-derived
ow velocity, or on abnormal pulse volumes
aused by stenosis. Although these methods have
erformed quite well for the detection of
oderate-to-severe disease in symptomatic pa-
ients, they also have well-recognized limitations.
esting pressure gradients do not develop until
nflow vessel stenosis becomes relatively severe
1,2). Current diagnostic methods are also poorly
uited to evaluating the impact of diffuse or
ultilevel disease and the influence of collateral
ow. They also provide little information on
bnormal microvascular functional responses that
an limit flow responses to exercise. A method for
valuating skeletal muscle perfusion and perfu-
ion reserve during exercise would potentially be
aluable for quantifying the total impact of the
complex pathophysiologic processes in
patients with limb ischemia, particularly
in those with diabetes in whom distal
arterial disease and abnormal microvas-
cular functional responses are common
(3,4). Perfusion assessment could also
play a valuable role in the development
and testing of therapies designed to
increase tissue perfusion.
See page 351
Noninvasive imaging techniques that com-
only are used to evaluate myocardial perfusion
n those with suspected coronary artery disease
ave not routinely been used in PAD largely
ecause of practical considerations of cost and
ime. There is also the need for quantitative
nformation because regional heterogeneity in
racer uptake cannot be used for diagnosis.
ontrast-enhanced ultrasound (CEU) is a quan-
itative perfusion imaging technique that has
ecently been applied to study skeletal muscle
ow responses to exercise, hyperinsulinemia, and
xogenous growth factor therapy (5–7) and to
uantify abnormal microvascular responses in
atients with insulin resistance (8). In this study,
e hypothesized that stress-rest perfusion imag-
ng of leg skeletal muscle with CEU could be
sed to detect PAD and evaluate its severity, and
ould be of particular value in patients with
ngiabetes mellitus (DM). pE T H O D S
tudy population. The study was approved by the
uman Investigation Committee. We studied 26
onsecutively recruited control subjects and 39 pa-
ients with documented PAD, of whom 19 had type
DM. All participants gave written informed
onsent. Control subjects were excluded for a his-
ory of coronary artery disease, hypertension mod-
rate or greater in severity (140/90 mm Hg),
yslipidemia, history of diabetes, or first-degree
elatives with diabetes determined on a prestudy
valuation. Control subjects were also excluded if
ody weight was 10% over ideal. Patients with
AD were enrolled if they had classic symptoms of
laudication and a history of at least one abnormal
iagnostic test (ABI, pulse volume recording
PVR], Doppler ultrasound, or angiography). Ex-
lusion criteria for PAD subjects were angina,
ongestive heart failure, ischemic ulcers of the lower
xtremity, or inability to perform walking exercise.
iabetes mellitus was defined by fasting blood
lucose 126 mg/dl on 2 or more studies and
icroangiopathic complications were defined by
ither recent eye examination (performed within 1
ear on all patients) and/or proteinuria.
rotocol. Blood was drawn in the fasting state and
BI measurement and PVRs were performed for
oth legs. A modified upright treadmill walking
xercise test was performed to determine the time
o development of claudication and claudication-
imited exercise time. Exercise was performed at a
alking speed of 2.0 mph with an initial of grade of
% that increased by 2% every 3 min (9). Pulmo-
ary oxygen consumption and minute ventilation
ere measured by a metabolic sensor system
VMax29, SensorMedics; Cardinal Health, Dublin,
hio). Subjects were instructed to report the onset
f claudication for each limb. Exercise was contin-
ed for 20 min unless terminated as the result of
ntolerable claudication or other limiting symptoms.
mmediate postexercise ABIs were measured. Sub-
ects underwent stress-rest CEU perfusion imaging
f the calf plantar-flexor muscles on a separate day.
BI and PVR. For ABI measurements, systolic blood
ressure of the brachial, dorsalis pedis, and poste-
ior tibialis arteries were measured bilaterally at rest
nd immediately after treadmill exercise in the
upine position (10). For each leg, the lowest
alculated ABI from either dorsalis pedis or poste-
ior tibialis was used. Bilateral lower-extremity
VRs were measured in the supine position byB B R E V I A T I O N S
N D A C R O N YM S
BI ankle-brachial index
EU contrast-enhanced
ltrasound
M diabetes mellitus
AD peripheral arterial
isease
VR pulse volume recordineumoplethysmography (1058-C Vascular Mini-
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345ab, Parks Medical Electronics, Las Vegas, Nevada)
ith cuffs placed at the thigh, calf, and foot at an
cclusion pressure of 60 mm Hg. The PVR studies
ere interpreted by a reader blinded to all other
linical and test data. Pulse volume recordings were
cored from 1 (normal) to 5 (severe disease) accord-
ng to a scale based on amplitude and phasic
aveform (10).
ngiography. Angiographic data were analyzed if
erformed without intervention within 3 months of
tudy participation. Disease severity was assessed by
n experienced vascular surgeon who was blinded to
ther study information. The severity of disease in
he inflow and outflow vessels was scored as: 1 
ormal, 2  minor irregularity or focal stenosis, 3
multiple nonhigh-grade or a discrete high-grade
70%) stenosis, 4  severe diffuse disease, and 5
total occlusion.
EU. Harmonic power-Doppler imaging (HDI-
000cv, Philips Ultrasound Systems, Bothell,
ashington) was performed at a transmission fre-
uency of 3.7 MHz with a linear-array transducer at
mechanical index of 1.1 to 1.2 and a pulse-
epetition frequency of 2.5 KHz. The plantar-flexor
uscles on both legs were imaged in the transaxial
lane during an intravenous infusion of lipid-
helled octafluoropropane microbubbles (Definity,
ristol-Myers Squibb Medical Imaging, New York,
ew York) at 0.20 to 0.27 ml/min. Images were
cquired during incremental prolongation of the
ulsing intervals (time between destructive pulses
rom 0.05 to 15 s). Imaging was performed first at
est for both limbs, then during plantar-flexion
xercise on a calibrated pedal ergometer with a
5-min separation period between limbs. For the
tress portion, image acquisition was started 2 min
nto exercise and completed within a total duration
f 4 min. Plantar flexion was performed every 5 s at
power (range 30 to 43 W) that was determined a
riori by the maximal resistance that a 60° plantar-
exion arc and return could be performed in 1 s.
Video intensity (VI) was measured from a
egion-of-interest placed over the entire gastrocne-
ius and soleus muscles (localized by fundamental
-mode imaging) after subtracting averaged frames
t a pulsing interval of 0.05 s to eliminate signal
rom tissue and large intramuscular vessels (5).
ime versus VI data were fit to the function: y 
(1 – et), where y is VI at time t; A is the plateau
I reflecting microvascular blood volume, and  is
he rate constant of blood transfer that reflects
icrovascular blood velocity (5,11). Blood flow wasetermined by the product of A and  (11), whereas cow reserve was calculated by the ratio of exercise to
est blood flow. In a group of 5 normal healthy
olunteers, average variability of blood flow mea-
ured on separate days was approximately 20% for
esting values and 15% for 80% maximal exercise
alues, but flow reserve varied by 10% in all cases.
tatistical methods. Data were analyzed with S-Plus
.3 (Insightful Inc., Seattle, Washington). Clinical
haracteristics and exercise data were analyzed as
ontingency data by the Fisher exact test for fre-
uency or percentage variables or by the Kruskall-
allis test and Wilcoxon rank-sum test for medi-
ns and interquartile ranges. The CEU and ABI
ata were analyzed via linear mixed models whereas
VR data and frequency data for the presence of
laudication and abnormal ABI were analyzed via
eneralized estimating equations models.
All hypothesis tests associated with clinical and
est values were 2-sided and Bonferronni correction
as applied when multiple tests were conducted on
he same variable. Time to claudication data were
nalyzed via the extension of the Cox proportional
azards regression model to multiple events per
ubject (12). Data were right censored for asymp-
omatic limbs when claudication in the contralateral
eg caused early test termination. Statistical tests on
roportional hazards were based on the robust
ersion of the Wald test (13). The quasi-likelihood
nformation criteria (14), along with the added
ariable robust Wald test, were used to derive the
est subset of variables to predict severity of disease.
E S U L T S
linical and laboratory variables. The clinical charac-
eristics for control subjects, PAD patients without
M, and PAD patients with DM are provided in
able 1.
xercise data and indicators of PAD. All control sub-
ects completed the 20-min treadmill walking exer-
ise protocol without symptoms of claudication or
ther limiting symptoms. Claudication occurred
uring treadmill exercise in all patients with PAD
nd was eventually severe enough to necessitate
remature termination of exercise in all but 2
atients. There were significant differences between
roups for total exercise duration, oxygen consump-
ion at peak exercise, and exercise time until the
nset of claudication (Table 2). More than one-half
f each of the PAD patient groups experienced
ilateral claudication before test termination.
Noninvasive test results (ABI, PVRs, and CEU)
ere significantly different for both PAD patient
ohorts compared with control subjects (Table 3).
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346n symptomatic limbs of patients with PAD and
M, the ABI at rest was normal (0.90) in 25%
espite the presence of claudication on treadmill
xercise. The bilateral rest-stress CEU perfusion
tudies were able to be completed without prema-
ure termination in all study subjects. The median
ower achieved during plantar flexion exercise was
ot significantly different between groups with a
linical Characteristics
Controls
(n  26)
PAD
(n  20)
PADDM
(n  19)
47 52 56†
rtile range 41–52 48–55 50–61
er, n (%) 11/26 (42) 11/20 (55) 7/19 (37)
bacco, n (%) 1/26 (4) 11/20 (55)* 9/19 (47)*
ia, n (%) 3/26 (12) 17/20 (85)* 19/19 (100)*
on, n (%) 2/26 (8) 13/20 (65)* 18/19 (95)*
index, kg/m2
23.5 27.2 31.3†
rtile range 21.8–25.7 24.2–28.6 27.7–35.9
s
r clopidogrel, n (%) 4/26 (15) 16/20 (80)* 16/19 (84)*
cker, n (%) 0/26 (0) 6/20 (30)* 8/19 (42)*
ARB, n (%) 1/26 (4) 9/20 (45)* 13/19 (68)*
(%) 1/26 (4) 10/20 (50)* 17/19 (89)*‡
n (%) 0/26 (0) 2/20 (10) 2/19 (11)
od studies
lesterol, mg/dl
n 121 104 93
uartile range 96–140 81–141 74–123
lesterol, mg/dl
n 51 41† 38*
uartile range 42–60 32–46 28–41
ides, mg/dl
n 85 127 143*
uartile range 72–120 81–188 110–215
oprotein
n 6.0 8.0 4.0
uartile range 4.3–6.8 4.8–13.0 3.0–6.3
mg/dl
n 0.8 3.0* 4.8*
uartile range 0.6–1.1 2.0–8.0 1.9–8.9
bin-A1c
n 5.2 5.6* 8.2*§
uartile range 5.0–5.3 5.5–5.7 7.1–10.5
plasma glucose, mg/dl
n 85 96* 182*§
uartile range 78–94 94–105 143–275
orrected p value: *p  0.01 versus control; †p  0.05 versus control; ‡p  0.05
§p  0.01 versus PAD.
giotensin-converting enzyme-inhibitor; ARB  angiotensin receptor blocker;
h-density lipoprotein; hs-CRP  high-sensitivity C-reactive peptide, LDL 
lipoprotein; Lp(a)  lipoprotein-(a); PAD  peripheral arterial disease.edian power of 38 W for all 3 groups. Comparedith control subjects, patients with PAD had lower
keletal muscle blood flow measured by CEU dur-
ng plantar flexion exercise and lower flow reserve
Table 3). These 2 variables were strong predictors
or the presence of PAD, even after adjusting for
ge and presence of diabetes with an adjusted odds
atios of 0.84 (95% confidence interval 0.77 to 0.91;
 0.001) for exercise blood flow by CEU and
.84 (95% confidence interval 0.75 to 0.94, p 
.002) for flow reserve.
In limbs with an ABI0.90 despite the presence
f claudication (n  14), exercise blood flow by
EU was impaired compared with control patient
imbs (A: 11.8  7.5 vs. 20.0  9.5, p 
.0005). Examples of CEU images and correspond-
ng quantitative data from a normal control subject
nd a symptomatic limb from a patient with PAD
nd DM are illustrated in Figure 1. Despite an
dentical power level for plantar flexion exercise (38
), the patient with PAD had a much smaller
ncrease in the peak VI (A-value, representing relative
icrovascular blood volume) and rate constant of the
efill curves (-value, representing microvascular
lood velocity) in response to exercise, resulting in a
uch smaller degree of flow reserve.
redictors of disease severity. Data on disease sever-
ty were censored for asymptomatic legs where
ymptoms in the contralateral leg caused early test
ermination. The CEU parameters of exercise
lood flow and flow reserve were univariate predic-
ors of disease severity defined by the claudication
hreshold for each leg (Fig. 2A). Stratified analysis
ssuming a different risk profile for PAD patients
ith DM revealed that the only predictors of PAD
Table 2. Treadmill Exercise Variables
Controls
(n  26)
PAD
(n  20)
PAD  DM
(n  19)
Exercise duration, min
Median 20.0 9.8* 4.5*†
Interquartile range 20–20 6.4–12.3 2.0–7.0
Peak VO2, ml/min/kg
Median 16.3 13.2* 8.7*†
Interquartile range 14.5–17.6 11.2–15.1 7.7–9.9
Metabolic units, METS
Median 4.7 3.7* 2.6*†
Interquartile range 4.2–5.0 3.2–4.1 2.3–2.9
Time to claudication, min
Median — 3.0 1.2†
95% conﬁdence interval — 2.1 to 6.0 0.6 to 2.5
Bilateral claudication, n (%) — 13/20 (65) 11/19 (58)
Bonferroni-corrected p value: *p  0.01 vs. control; †p  0.01 vs. control.
DM  diabetes mellitus; PAD  peripheral arterial disease; VO2  oxygenTable 1. C
Age, yrs
Median
Interqua
Male gend
Current to
Dyslipidem
Hypertensi
Body mass
Median
Interqua
Medication
Aspirin o
Beta blo
ACE-I or
Statin, n
Fibrate,
Fasting blo
LDL cho
Media
Interq
HDL cho
Media
Interq
Triglycer
Media
Interq
Lp(a) lip
Media
Interq
hs-CRP,
Media
Interq
Hemoglo
Media
Interq
Fasting
Media
Interq
Bonferroni-c
versus PAD;
ACE-I  an
HDL  higconsumption.
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347everity were the CEU measurements of exercise
ow and flow reserve (Fig. 2B). On multivariate
nalysis, both of these parameters added incremen-
al benefit to clinical and other test variables and the
est predictive models for severity of disease were
he presence of DM together with either exercise
lood flow or flow reserve on CEU (Fig. 3).
Angiographic data was available in 19 patients
ith PAD. Combined angiographic severity score
n patients without DM correlated moderately well
ith CEU data on exercise blood flow (r  0.70,
EE  5.2, p  0.003) and flow reserve (r  0.56,
EE  2.4, p  0.047). In PAD patients with
M, angiography did not correlate with either of
he CEU parameters, nor did it correlate with time
o claudication, ABI, or PVR score. Angiographic
everity score for inflow vessels only did not corre-
ate with any noninvasive test in any of the cohorts.
I S C U S S I O N
n this study, we have demonstrated that CEU
maging of skeletal muscle microvascular blood flow
nd flow reserve provides information on the pres-
Figure 1. CEU Data From a Normal Subject and a Patient With P
Images were obtained at incremental pulsing intervals in seconds (s) a
muscles at rest and during exercise in a limb from a control subject (A
each panel, rest images are above and exercise images are below. Des
and ﬂow reserve were markedly impaired in the patient with peripher
image. BG  background image obtained immediately after microbubblence and severity of PAD in symptomatic patients.
t was particularly useful in the diabetic population
n whom conventional non-invasive tests were less
redictive of the severity of symptoms.
The application of perfusion imaging to evaluate
AD in this study was a response to several emerg-
orresponding time versus intensity data from the calf plantar ﬂexor
d a patient with peripheral arterial disease and claudication (B). For
an identical workload for the 2 patients (38 W), exercise blood ﬂow
terial disease (PAD). Color scale is shown at bottom of the ﬁrst
Table 3. Noninvasive Test Values
Controls
(n  26)
PAD
(n  20)
PA
(n
ABI
Mean  SD 1.15 0.10 0.74 0.19* 0.7
Postexercise ABI
Mean  SD 1.14 0.13 0.56 0.30* 0.6
CEU exercise blood ﬂow (A)
Mean  SD 20.0 9.5 10.4 6.7* 7
CEU ﬂow reserve
Mean  SD 13.1 11.2 6.3 5.0* 7
PVR score
Mean  SD 1.0 0 2.4 0.9* 2
Claudication and ABI 0.90, n (%) — 6/40 (15) 8
Bonferroni-corrected p value: *p  0.05 versus control.
ABI  ankle-brachial index, CEU  contrast-enhanced ultrasound, DM  diabet
PAD  peripheral arterial disease; PVR  pulse volume recording.AD
nd c
) an
pite
al arD  DM
 19)
9 0.27*
3 0.31*
.9 5.9*
.4 5.0*
.8 0.5*
/36 (25)
es mellitus;destruction; CEU  contrast-enhanced ultrasound.
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348ng clinical needs. Elderly and diabetic patients
onstitute an increasing proportion of patients with
AD. The diagnostic performance of conventional
echniques such as ABI, PVR, and Doppler ultra-
ound is reduced in these patients because of vas-
ular noncompliance caused by medial arterial cal-
inosis, greater likelihood for diffuse or distal
isease, and functional abnormalities of the micro-
irculation (15,16). For this reason, for any given
eduction in ABI reduction, patients with DM tend
o have more impairment in lower-extremity func-
ional capacity than those without DM (17).
There is also a growing need to detect modest
isease where early risk factor modification or other
orms of secondary prevention could potentially
low disease progression and improve overall car-
iovascular risk that is high in patients with PAD
18–20). Conventional diagnostic tests are not
ell-suited for detecting mild-to-moderate disease
ecause pressure gradients and reduced resting flow
re features of relatively advanced disease (1,2). In
his study of patients with symptomatic PAD, the
se of CEU added diagnostic information, partic-
larly in diabetic patients and in patients with limb
0 1 2 3 4 5
 Factor Hazard Ratio P Value
(95% CI)
0.76 (0.49 to 1.17) 0.21
es : No) 2.46 (1.32 to 4.56) 0.004
1.40 (1.08 to 1.80) 0.01
0.77 (0.49 to 1.20) 0.25
I 0.69 (0.37 to 1.32) 0.26
w 0.69 (0.54 to 0.88) 0.004
eserve 0.75 (0.55 to 1.01) 0.06 
Hazard Ratio [95% CI]
0 0.5 1.0 1.5 2.0
 Factor Hazard Ratio P Value
(95% CI)
0.65 (0.43 to 1.00) 0.05
1.07(0.97 to 1.19) 0.16
0.80 (0.54 to 1.20) 0.29
I 0.66 (0.36 to 1.22) 0.19
w 0.67 (0.51 to 0.88) 0.003
eserve 0.64 (0.46 to 0.89) 0.008 
Hazard Ratio [95% CI]
Predictors of Disease Severity
f disease severity were deﬁned as exercise treadmill time until the
udication before (A) and after (B) stratiﬁcation according to the
f diabetes mellitus. ABI  ankle-brachial index; CI  conﬁdence
 diabetes mellitus; Ex  exercise; PVR  pulse volume recording.laudication but an ABI value of 0.90. Detection tf disease in these individuals is important not only
or preventing disease progression, but also because
t identifies patients with increased risk for adverse
ardiovascular events, even when ABI values are
ormal or elevated (20).
There is also clinical and research utility for
ccurate quantification of disease severity. This
nformation could help determine the origin of
typical symptoms that are common in PAD (21).
echniques that rely on measurement of pressure
radients or resting flow are limited in their ability
o measure severity of disease when in the mild-to-
oderate range because of the complex and non-
inear relation of these parameters with stenosis
everity (1,2). Although large population studies
ave demonstrated a relationship between ABI and
ymptoms, normal ABIs are commonly encoun-
ered in patients with symptomatic PAD (22).
Moreover, carefully performed studies examining
ower-extremity functional capacity demonstrated
hat performance is not well differentiated in the
elatively wide range of ABI values of 0.5 to 0.9
23). The ability to accurately measure tissue blood
ow may also be important for evaluating responses
o conventional therapies or emerging pro-
ngiogenic therapies. Underscoring this issue, re-
ent studies with autologous bone-marrow mono-
uclear cell transplantation in patients with severe
AD have indicated that symptomatic improve-
ent in individual limbs often occurs independent
f any significant change in the ABI (24,25).
oreover, in one of these studies the baseline ABI
alue was normal in one third of limbs despite the
iagnosis of thromboangiitis obliterans (25).
It has been shown in a canine model of femoral
rtery stenosis that CEU can detect mild to moderate
mpairment in flow and flow reserve (26). These
ndings formed the basis for the current clinical study.
erfusion imaging also has the advantage of being able
o evaluate functional abnormalities in microvascular
ow in patients with DM, including potential loss of
he ability to redistribute flow between limb tissues or
etween nutritive and non-nutritive circuits within
uscle during exercise (27) or impaired neurogenic
ascular responses further upstream (28). In this study,
here was a potential selection bias toward conven-
ional techniques because of the entry criteria of
stablished diagnosis of PAD based on at least one
bnormal diagnostic test. Yet, CEU provided addi-
ional diagnostic value for detecting the severity of
ymptomatic PAD. In particular, CEU added predic-A Risk
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349iagnostic tests that rely on pressure gradients are
isadvantaged.
It should be noted that other methods for skeletal
uscle perfusion have been developed that are based
n transit-rate analysis after bolus injection of ultra-
ound contrast material (29). With this technique, the
ime to peak contrast enhancement after an intrave-
ous injection was able to distinguish differences in
erfusion in patients with severe PAD (median ABI
.5) from control individuals. This technique has
dvantages in its simplicity although, unlike the meth-
ds used in this study, differences in cardiac output,
njection rate, or volume of distribution will affect time
o peak values (30).
tudy limitations. The major limitation of this study
as the lack of a true gold standard for evaluating the
mpact of proximal and distal disease, and functional
mpairments. In this regard, it can only be considered
n exploratory study without true validation against
ther methods such as positron emission tomography
r blood oxygenation level-dependent magnetic reso-
ance imaging that can be used to evaluate blood flow
ut may not be suited for routine screening purposes.
lso, toe pressures were not measured in this study
nd may have provided better information on distal
ascular impairment.
Angiographic data were available in a subset of
atients but could not be considered a true gold
tandard because of the complex anatomic and
unctional determinants of capillary flow. This issue
s exemplified by the poor relationship between
ngiography and all other predictors of disease
everity in patients with DM. It should also be
oted that entry criteria of known symptomatic
AD with classic claudication selected for patients
ith moderate disease in whom the test may have
he most value. We had to exclude patients with
evere disease because of failure to perform exercise.
his exploratory study will need to be followed with
uture studies to evaluate the incremental diagnostic
alue of CEU in patients referred for initial diag-
ostic testing or screening asymptomatic-but-high-
isk populations, or for determining relative value in
hose with severe disease where the diagnostic value
f the test is likely to be less.
O N C L U S I O N S
tress-rest CEU provides important information on
he presence and severity of PAD, and the total
mpact of complex disease on microvascular perfu-
ion. The technique may be able to detect more
odest disease than conventional techniques and,ence, could be valuable for adopting a strategy of Primary preventive strategies in PAD. Tissue per-
usion imaging by CEU also holds promise for
etermining the efficacy of conventional or experi-
ental therapeutic interventions. The feasibility for
sing CEU in routine clinical practice or in clinical
rials is supported by the practical advantages of the
echnique such as speed, low cost, and current
vailability of technology in most vascular labs.
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